AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease
New England Journal of Medicine · 2025
DOI: 10.1056/nejmoa2407766 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, 2025. Verfasst von Xiuwei Ma und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chinese People's Liberation Army (PLA) General Hospital, Beijing. Hauptthemen laut MEDLINE: alpha-Glucosidases, Dependovirus, Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Peking University, National Natural Science Foundation of China, National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Chinese People's Liberation Army (PLA) General Hospital, Beijing.
- Department of Pediatric Medicine, Seventh Medical Center of Chinese PLA General Hospital, Beijing.
- National Engineering Laboratory for Birth Defects Prevention and Control of Key Technology, Beijing.
- Beijing Key Laboratory of Pediatric Organ Failure, Beijing.
- Genecradle Therapeutics, Beijing.
- Ultrasonic Department, Seventh Medical Center of Chinese PLA General Hospital, Beijing.
ORCID-Profile: Jun Li, Zhichun Feng
Förderung
- Peking University
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital
Zitieren
APA
Ma, X., Zhuang, L., Ma, W., Li, J., Mao, Y., Wang, J., Wang, X., Xu, J., Yu, S., Gu, R., Wang, Y., Li, Z., Jiang, X., Zhang, S., He, F., Yang, X., Zhu, L., Zhang, S., Zhang, Y., …, & Feng, Z. (2025). AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2407766
Vancouver
Ma X, Zhuang L, Ma W, Li J, Mao Y, Wang J, et al. AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease. New England Journal of Medicine. 2025. doi:10.1056/nejmoa2407766
BibTeX
@article{Ma2025,
author = {Ma, Xiuwei and Zhuang, Lu and Ma, Wenhao and Li, Jun and Mao, Yingying and Wang, Jianhua and Wang, Xiaodong and Xu, Juan and Yu, Shuangqing and Gu, Ruijie and Wang, Yongxia and Li, Zhongqiu and Jiang, Xinyang and Zhang, Sheng and He, Fang and Yang, Xiao and Zhu, Lina and Zhang, Shan and Zhang, Yanping and Li, Ting and Li, Qiuping and Wu, Zhijie and Zhang, Cengceng and Zhang, Yiying and Dong, Xiaoyan and Xiong, Hui and Wu, Xiaobing and Feng, Zhichun},
title = {AAV9-Mediated Gene Therapy for Infantile-Onset Pompe’s Disease},
journal = {New England Journal of Medicine},
year = {2025},
doi = {10.1056/nejmoa2407766}
}
EUVIMED